Showing results (81-90 of 163) with videos related to
Sort By:
Pageof 17
Biomicrofluidics|October 10, 2013
A microfluidic device for on-chip agarose microbead generation with ultralow reagent consumptionLinda Desbois, Adrien Padirac, Shohei Kaneda, et al.Frontiers in Neuroscience|October 19, 2013
Programming of neuroendocrine self in the thymus and its defect in the development of neuroendocrine autoimmunityVincent Geenen, Gwennaëlle Bodart, Séverine Henry, et al.Viruses|July 5, 2019
Coxsackievirus-B4 Infection of Human Primary Pancreatic Ductal Cell Cultures Results in Impairment of Differentiation into Insulin-Producing CellsAntoine Bertin, Famara Sane, Valery Gmyr, et al.Reviews in Medical Virology|November 6, 2024
Enterovirus Antibodies: Friends and FoesChaldam Jespère Mbani, Corentin Morvan, Magloire Pandoua Nekoua, et al.Current Microbiology|September 1, 2017
Evaluation of Contamination Risks with Coxsackievirus B4 E2 in Swiss Albino Mice StoolsLeïla Aguech-Oueslati, Hela Jaidane, Famara Sane, et al.Journal of Tropical Medicine|August 11, 2025
Evaluation of a Fully Automated Assay for Detection of Antidengue IgM Antibodies in a Nonendemic AreaAurélie Guigon, Pauline Coulon, Laura Pezzi, et al.Microorganisms|February 12, 2021
Fluoxetine Can Inhibit SARS-CoV-2 In VitroArthur Dechaumes, Magloire Pandoua Nekoua, Sandrine Belouzard, et al.The Journal of Molecular Diagnostics : JMD|January 1, 2021
A Real-Time Quantitative PCR Targeting the Viral Vector for the Monitoring of Patients Treated with Axicabtagene CiloleucelAgathe Baras, Laurence Bocket, David Beauvais, et al.Diagnostic Microbiology and Infectious Disease|February 22, 2018
Comparison of two commercial quantitative PCR assays and correlation with the first WHO International Standard for human CMVIlka Engelmann, Enagnon Kazali Alidjinou, Mouna Lazrek, et al.European Journal of Clinical Investigation|June 26, 2015
Monocytes of Patients with Type 1 Diabetes Harbour Enterovirus RNAEnagnon Kazali Alidjinou, Wassim Chehadeh, Jacques Weill, et al.Pageof 17